Αποτελέσματα Αναζήτησης
Nutritional interventions for mitochondrial disorders regulated by U.S. Food and Drug Administration (FDA) that were included within the scope of this workshop fall into three general categories: (1) dietary supplements (2) medical foods, such as those used with the ketogenic diet; and (3) FDA-approved drugs that are also available as dietary ...
- Understanding mitochondrial myopathies: a review - PMC
Diet: Dietary needs are extremely variable from patient to...
- Understanding mitochondrial myopathies: a review - PMC
12 Ιουν 2024 · Specialists in the Mitochondrial Disease Clinic evaluate many types of mitochondrial diseases. Alpers progressive sclerosing poliodystrophy (Alpers disease). Barth syndrome.
Diet: Dietary needs are extremely variable from patient to patient with mitochondrial myopathies. It is required to evaluate a patient’s nutritional deficiencies. Potential therapies include supplementing caloric intake, enteral feeding, increasing the frequency of meals, limited fasting, and parenteral nutrition ( Parikh et al., 2009 ).
This review is aimed at a general medical and neurologist readership and provides a clinical approach to the recognition, investigation, and treatment of mitochondrial myopathies. Emphasis is placed on practical management considerations while including some recent updates in the field.
General Guidelines . 4-6 small meals a day . include complex carbohydrate and protein at each meal. maintain a healthy weight.
Both nonpharmacological therapy (calcium and vitamin D supplementation, weight-bearing exercise, and fall prevention) and pharmacological treatments (antiresorptive and anabolic agents) may be helpful in the prevention and treatment of osteoporosis.
14 Φεβ 2024 · We performed a retrospective chart review of adult patients diagnosed with mitochondrial myopathy at Mayo Clinic (2005–21). We identified 94 patients. Median time from symptom onset to diagnosis was 11 years (interquartile range 4–21 years). Median age at diagnosis was 48 years (32–63 years).
